Registration

ML STRATEGIES, LLC for MSS, INC. (ON BEHALF OF SHANGHAI LIANGRUN BIOMEDICINE TECHNOLOGY CO.)

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to COVID-19 serology test

LobbyistCovered position, as disclosed
ALEXANDER NATHAN HECHT New Chief Counsel, Senate Committee on Small Business & Entrepreneurship
AARON JOSEPHSON New —

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
SHANGHAI LIANGRUN BIOMEDICINE TECHNOLOGY CO. LTD. China China 100.0% —

Affiliated organisations

OrganisationLocation
SHANGHAI LIANGRUN BIOMEDICINE TECHNOLOGY CO. LTD. Shanghai, CN

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.